The Road Ahead: Wellcome Trust/DBT India Alliance Enters Next Phase of Funding and Innovation
29 Mar 2019
The Wellcome Trust/DBT India Alliance (India Alliance) has evolved from a novel experiment to a leader in science funding in India in a period of 10 years (2008-2019). Progress on the objectives that we had set for ourselves—to identify the best researchers and nurture them, build excellence in biomedical research, and help the Indian research ecosystem to rise to international standards—all demanded innovative approaches, scientific and technological advances, and creative investments. This equal partnership of DBT and Wellcome Trust, over 10 years, has fulfilled its objectives of enabling cutting-edge biomedical research in India and nurturing the talent of highest global standards.
Now, an exciting future is at the horizon, thanks to the visionary leadership of the Government of India and our funders: the Department of Biotechnology (DBT), Government of India and the Wellcome Trust (UK).
The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, approved the continuation of India Alliance, beyond its initial 10-year term (2008-09 to 2018-19) to five-year phase (2019-20 to 2023-24). In this phase, DBT increases its commitment to two times of that of the Wellcome Trust. The total financial implication will be INR 1092 crore with DBT and Wellcome Trust contributing INR 728 crore and INR 364 crore, respectively.
Mike Turner, Director of Science at the Wellcome Trust, said: “We’re delighted that the Cabinet of the Government of India has approved a new five-year phase of the Wellcome Trust/DBT India Alliance. Over the last 10 years, this partnership has supported the growth of Indian biomedical science, led to new international partnerships and helped develop the careers of researchers. We look forward to building on this work as the India Alliance now introduces three new initiatives which will fund collaborative research projects, clinical research centres, and clinical training.”
The programme has celebrated a decade of growth across an unmatched portfolio of globally competitive fellows and biomedical research projects. It has facilitated important scientific breakthroughs and contributed significantly to the growth in the number of and geographical span of institutions were internationally competent research is undertaken. In the next phase, the India Alliance would continue to build this capacity as also strengthen clinical research.
“At India Alliance, it is a proud moment for us owing to the confidence reposed in us by the Government of India, DBT, and Wellcome Trust in approving the next phase with increased funding. This brings exciting opportunities, which we will use to create new benchmarks for research funding, engagement and ecosystem development,” said Dr Shahid Jameel, CEO, India Alliance.
Moving ahead, the India Alliance will amplify its efforts and diversify into areas of greatest need with an aim to build excellence in Indian science, establish a globally recognised research ecosystem and empower our researchers to drive policy and solve important health problems for India.
Find the press release from PIB here.
Glimpses from the 10-year journey of India Alliance can be seen at our commemorative webpage.